Sorafenib was reported to significantly increase the peripheral recruitment and intratumoral infiltration of macrophages in metastatic liver cancer, accompanied by an elevation of SDF-1α, CSF-1, and VEGF in the tumor stroma [54]. This evidence concerns the gene CSF1 and neoplasm.